LPCAT1, TERT, MSH2 and SLC6A3 were consistently associated with endometrial cancer risk across the three models (deletions-only, duplications-only and loss of function), suggesting a shared loss of function mechanism across CNV type. This evidence concerns the gene LPCAT1 and endometrial cancer.